title: Spontaneous reports of seizure in association with leuprolide (lupron depot), goserelin (zoladex implant), and naferelin (synarel nasal spray).
authors: U.S. Food and Drug Administration Office of Surveillance and Epidemiology Silver Spring, Maryland.
authors: Jasmine
authors: J
authors: Gatti
authors: Allen
authors: A
authors: Brinker
authors: Mark
authors: M
authors: Avigan
mesh_terms: D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D003692:Delayed-Action Preparations; D005260:Female; D005300:Fertility Agents, Female / Q000009:adverse effects*; D017273:Goserelin / Q000009:adverse effects*; D006801:Humans; D016729:Leuprolide / Q000009:adverse effects*; D017274:Nafarelin / Q000009:adverse effects*; D059085:Nasal Sprays; D012640:Seizures / Q000139:chemically induced*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D003692:Delayed-Action Preparations; D005300:Fertility Agents, Female; D059085:Nasal Sprays; D017273:Goserelin; D017274:Nafarelin; D016729:Leuprolide
references: Herzog AG. Catamenial epilepsy: definition, prevalence, pathophysiology and treatment. Seizure 2008;17:151–9.